Shares of GeoVax Labs, Inc. (NASDAQ:GOVXW – Get Free Report) traded up 40.4% on Thursday . The company traded as high as $0.18 and last traded at $0.17. 7,345 shares changed hands during trading, a decline of 55% from the average session volume of 16,415 shares. The stock had previously closed at $0.12.
GeoVax Labs Price Performance
The stock’s 50-day moving average is $0.12 and its two-hundred day moving average is $0.16.
GeoVax Labs Company Profile
GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers.
Further Reading
- Five stocks we like better than GeoVax Labs
- Pros And Cons Of Monthly Dividend Stocks
- 3 Defense Stocks Gaining From Budget and Interest Rate Pressures
- Dividend Capture Strategy: What You Need to Know
- 3 Natural Gas Stocks Set to Thrive in This Winter’s Freeze
- Best Stocks Under $10.00
- Bullish on Athleisure? Here’s Why Lululemon Stock Shines
Receive News & Ratings for GeoVax Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeoVax Labs and related companies with MarketBeat.com's FREE daily email newsletter.
